Retailers Cut Midtrial Deal With Impax In Opana Delay Case
Well into an antitrust trial over an alleged pay-for-delay scheme surrounding Endo Pharmaceuticals' Opana ER painkiller, a group of major retail chains cut a midtrial settlement Friday with Impax Laboratories, one of the defendants in...To view the full article, register now.
Already a subscriber? Click here to view full article